
Sign up to save your podcasts
Or


Join Drs Curigliano and Hurvitz as they discuss advances in systemic treatments for HER2-positive, triple-negative, and HR-positive breast cancer.
Credit available for this activity expires: [10/26/22]
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/961439?src=mkm_podcast_addon_961439
By Medscape Podcasts4
77 ratings
Join Drs Curigliano and Hurvitz as they discuss advances in systemic treatments for HER2-positive, triple-negative, and HR-positive breast cancer.
Credit available for this activity expires: [10/26/22]
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/961439?src=mkm_podcast_addon_961439

1,257 Listeners

317 Listeners

498 Listeners

299 Listeners

1,388 Listeners

171 Listeners

883 Listeners

14 Listeners

16 Listeners

298 Listeners

3,348 Listeners

8,554 Listeners

194 Listeners

515 Listeners

367 Listeners

60 Listeners

28 Listeners

426 Listeners